Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colonoscopy complications and associated costs and mortality in a Swedish colorectal cancer screening program.

Endoscopy·2026
Same author

HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to Fluoroquinolones.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

An update on drug-induced liver injury-What's new?

Journal of internal medicine·2026
Same author

Exploring the influence of sex on <i>idiosyncratic</i> DILI: impact on risk assessment.

Expert opinion on drug metabolism & toxicology·2026
Same author

Colonoscopy in elderly patients: diagnostic yield, pre-referral assessment and quality indicators in two Swedish cohorts.

Scandinavian journal of gastroenterology·2026
Same author

Open vs Intact Pleura During Internal Thoracic Artery Harvesting: A Meta-Analysis of Randomized Trials.

The Annals of thoracic surgery·2026

Related Experiment Videos

Acute upper gastrointestinal bleeding: a population-based cohort study from Southern Iceland.

Vigdis S Sverrisdottir1, Johann P Hreinsson2,3, Arnar B Ingason4

  • 1Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Scandinavian Journal of Gastroenterology
|June 29, 2026
PubMed
Summary

Acute upper gastrointestinal bleeding (AUGIB) incidence in Iceland is low and decreasing. Most AUGIB patients were admitted, but triage was effective, with few interventions for discharged individuals.

Keywords:
Gastrointestinal hemorrhageclinical outcomesendoscopyhematemesisincidencemelena

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Epidemiology
  • Public Health

Background:

  • Acute upper gastrointestinal bleeding (AUGIB) is a frequent cause of emergency room visits, associated with significant morbidity and mortality.
  • Existing research often overlooks outcomes for patients not requiring hospital admission.
  • This study addresses the gap by examining all AUGIB presentations, irrespective of admission status.

Purpose of the Study:

  • To determine the incidence and outcomes of all acute upper gastrointestinal bleeding (AUGIB) presentations.
  • To assess the utilization of prediction models in managing AUGIB cases.
  • To evaluate patient characteristics, treatment patterns, and mortality rates across admitted and non-admitted groups.

Main Methods:

  • Retrospective chart review of all AUGIB cases at Landspitali University Hospital, Iceland (2017-2023).
  • Calculation of AUGIB incidence using Poisson regression for the hospital's catchment area.
  • Analysis of patient demographics, endoscopy findings, outcomes, and survival using Kaplan-Meier methods.

Main Results:

  • A total of 1129 AUGIB cases were identified among 1017 individuals, with an overall annual incidence of 75/100,000, showing a decreasing trend.
  • Admitted patients (67%) were significantly more likely to undergo endoscopy and receive blood transfusions compared to non-admitted patients.
  • Thirty-day all-cause mortality was higher in admitted patients (6.7%) versus non-admitted (0.9%), with the Glasgow-Blatchford score reported in only 1% of cases.

Conclusions:

  • The incidence of acute upper gastrointestinal bleeding (AUGIB) in Iceland is low and declining.
  • A significant proportion of AUGIB patients were managed without hospital admission, indicating effective initial triage.
  • Despite limited use of prediction models like the Glasgow-Blatchford score, patient management appeared appropriate, with minimal interventions for discharged individuals.